These brand-named GLP-1/GIP medications are very expensive and have been in short supply for diabetics
1 In 2024, 6% of United States (US) adults report current GLP-1 use, and 12% report current or past userising to 22% among individuals told by a clinician that they have overweight or obesity
Trustpilot removes profiles for reasons including fake or incentivized reviews, flagging-tool abuse, and brand misuse
Safety checks and double-verification protocol Accurate dosing is not just about math
In the primary analysis measuring development of nonexudative AMD, GLP-1 receptor agonist use was associated with an 83.5% (RR, 0.16), 86.7% (RR, 0.13) and 91.3% (RR, 0.09) reduced risk of developing the disease at five, seven and 10 years, respectively, compared to the OWLDs cohort
All of those facilities made sterile injectables, one of those facilities made semaglutide and tirzepatide, and one had acquired at least one bulk drug from an unregistered supplier